2 completed, 1 terminated. 1 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Emergency Use Authorization: new trials by email Literature Review of Emergency Use Authorization trials Research Report on Emergency Use Authorization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| THEMBA II T-Cell Vaccine: Vaccination With saRNA COVID-19 Vaccines AAHI-SC2 Vaccine, AAHI-SC3 Vaccine, EUA or approved vaccine - COVID-19 | Phase 1 / Phase 2 | Terminated | ImmunityBio, Inc. | 60 | 2022-05-05 | 2025-03-11 |
| Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study intravitreal bevacizumab injection(1.25mg) - Diabetic Macular Edema | Phase 3 | Completed | University of Sao Paulo | 41 | 2009-02-01 | 2014-12-04 |
| Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas EUA with seton placement if necessary, adalimumab, EUS - Crohn Disease, Rectal Fistula | Phase 4 | Completed | Vanderbilt University Medical Center | 21 | 2008-01-01 | 2017-04-21 |
COVID-19 (1) · Crohn Disease (1) · Diabetic Retinopathy (1) · Rectal Fistula (1)
ImmunityBio, Inc. (1) · University of Sao Paulo (1) · Vanderbilt University Medical Center (1)
Brazil (1) · South Africa (1) · United States (1)